TEX36-AS1: A Potential Drug Target and Biomarker (G100169752)

Target Name: TEX36-AS1

NCBI ID: G100169752

TEX36-AS1

Other Name(s): TEX36 antisense RNA 1

TEX36-AS1: A Potential Drug Target and Biomarker

The protein TEX36-AS1 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. TEX36-AS1 is a transmembrane protein that is expressed in various tissues and cells, including neurons, glial cells, and blood vessels. Its unique structure and expression patterns make it an attractive target for drug development due to its potential to modulate cellular behavior and processes.

Disease-Related TEX36-AS1 Expression

TEX36-AS1 has been shown to be involved in various cellular processes that are relevant to several diseases. Its expression has been associated with the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. TEX36-AS1 has also been shown to be involved in cancer, including breast, ovarian, and colorectal cancers.

In addition to its association with disease, TEX36-AS1 has also been shown to be a potential biomarker for several diseases. Its expression has been used as a biomarker for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. TEX36-AS1 has also been shown to be a potential biomarker for cancer, including breast, ovarian, and colorectal cancers.

Targeting TEX36-AS1

The potential drug target for TEX36-AS1 is its role in modulating the activity of various signaling pathways that are involved in cellular processes that are relevant to disease. One of the primary targets for TEX36-AS1 is the TGF-β pathway, which is involved in cell growth, differentiation, and survival. TGF-β signaling is a critical pathway that is involved in the development and maintenance of tissues and organs, including neurons and glial cells.

In TGF-β signaling, TEX36-AS1 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. It has been shown to promote the growth and survival of neural stem/progenitor cells, which are important for the development and maintenance of neural tissues. In addition, TEX36-AS1 has been shown to inhibit the negative regulation of cell proliferation by the TGF-β signaling pathway, which may contribute to the development of cancer.

Another potential target for TEX36-AS1 is the NF-kappa-B signaling pathway, which is involved in inflammation, immune response, and cellular signaling. TEX36-AS1 has been shown to play a role in the regulation of NF-kappa-B signaling, which may contribute to the development of autoimmune diseases.

Biomarker Potential

The potential use of TEX36-AS1 as a biomarker for disease has been shown through several studies. For example, researchers have used TEX36-AS1 as a biomarker for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These studies have shown that TEX36-AS1 levels are decreased in the brains of individuals with these diseases, and that TEX36-AS1 has been shown to promote the growth and survival of neural stem/progenitor cells, which are important for the development and maintenance of neural tissues.

In addition to its potential as a biomarker, TEX36-AS1 has also been shown to be a potential drug target for several diseases. Its expression has been associated with the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. TEX36-AS1 has also been shown to be involved in cancer, including breast, ovarian, and colorectal cancers.

Conclusion

In conclusion, TEX36-AS1 is a protein that has been identified as a potential drug target and biomarker for several diseases. Its unique structure and expression patterns make it an attractive target for drug development due to its potential to modulate cellular behavior and processes. Further research is needed to fully understand the role of TEX36-AS1 in disease and to develop effective treatments.

Protein Name: TEX36 Antisense RNA 1

The "TEX36-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TEX36-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets